Parabilis Medicines, Inc. (PBLS) stock
PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.44−0.18 (-0.67%)
Close on Nov 20, 2026Market cap $3.39BP/E –Yield –
Parabilis Medicines operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$50.89M | – |
| Q2 FY2025 | Jun 30, 2025 | -$36.52M | – |
See a number that looks wrong?